Owlet (NYSE:OWLT – Get Free Report) and Cardlytics (NASDAQ:CDLX – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.
Volatility & Risk
Owlet has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, Cardlytics has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500.
Earnings & Valuation
This table compares Owlet and Cardlytics”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Owlet | $78.10 million | 1.86 | -$12.54 million | ($3.50) | -2.43 |
Cardlytics | $266.20 million | 0.47 | -$189.30 million | ($3.65) | -0.65 |
Owlet has higher earnings, but lower revenue than Cardlytics. Owlet is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Owlet and Cardlytics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Owlet | -54.45% | -0.36% | -3.26% |
Cardlytics | -68.87% | -279.39% | -48.17% |
Institutional & Insider Ownership
72.6% of Owlet shares are held by institutional investors. Comparatively, 68.1% of Cardlytics shares are held by institutional investors. 52.2% of Owlet shares are held by company insiders. Comparatively, 4.4% of Cardlytics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Owlet and Cardlytics, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Owlet | 1 | 0 | 2 | 1 | 2.75 |
Cardlytics | 1 | 3 | 0 | 1 | 2.20 |
Owlet presently has a consensus target price of $10.25, indicating a potential upside of 20.42%. Cardlytics has a consensus target price of $2.25, indicating a potential downside of 5.06%. Given Owlet’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Owlet is more favorable than Cardlytics.
Summary
Owlet beats Cardlytics on 12 of the 14 factors compared between the two stocks.
About Owlet
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
About Cardlytics
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.